River Road Asset Management LLC Boosts Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

River Road Asset Management LLC raised its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 439.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 462,660 shares of the company’s stock after buying an additional 376,958 shares during the quarter. River Road Asset Management LLC owned approximately 0.10% of GE HealthCare Technologies worth $35,773,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Barclays PLC acquired a new position in GE HealthCare Technologies during the 2nd quarter worth approximately $92,462,000. Thrivent Financial for Lutherans acquired a new position in GE HealthCare Technologies during the 2nd quarter worth approximately $1,590,000. MML Investors Services LLC acquired a new position in GE HealthCare Technologies during the 2nd quarter worth approximately $929,000. Schonfeld Strategic Advisors LLC acquired a new position in GE HealthCare Technologies during the 2nd quarter worth approximately $3,474,000. Finally, Tower Research Capital LLC TRC acquired a new position in GE HealthCare Technologies during the 2nd quarter worth approximately $1,150,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

GEHC traded down $0.69 during trading on Wednesday, reaching $85.19. 1,711,216 shares of the company were exchanged, compared to its average volume of 3,426,849. The company has a current ratio of 1.05, a quick ratio of 0.83 and a debt-to-equity ratio of 1.18. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50. The firm has a 50 day moving average of $88.55 and a 200 day moving average of $77.60. The stock has a market cap of $38.87 billion, a P/E ratio of 28.32, a PEG ratio of 3.00 and a beta of 0.94.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The company had revenue of $5.20 billion during the quarter, compared to analyst estimates of $5.09 billion. During the same quarter in the previous year, the firm posted $1.31 EPS. The firm’s quarterly revenue was up 5.3% on a year-over-year basis. On average, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be issued a $0.03 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.97%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. Citigroup boosted their price target on GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Evercore ISI upped their target price on GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research report on Thursday, April 4th. HSBC initiated coverage on GE HealthCare Technologies in a research report on Thursday, February 15th. They issued a “buy” rating and a $100.00 target price on the stock. Morgan Stanley boosted their price target on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a report on Monday, February 12th. Finally, Mizuho boosted their price target on GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, April 11th. Four equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $95.08.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.